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ABSTRACT 
Background and Objectives: Patients at intensive-care-unit (ICU) are at risk of acquiring nosocomial infections which 
contributes to higher  rates. Approximately 25% of all hospital infections and 90% of outbreaks occur in ICUs. Multi-
resistant gram-negative rods are important pathogens in ICUs, causing high rate of mortality. The purpose of this study 
was to investigate the antimicrobial resistance patterns among common Gram-negative bacilli isolated from patients with 
nosocomial infection at Army Hospitals. 
Materials and Methods: A total of 187 isolates of Gram-negative bacilli were isolated from 904 patients at ICUs of three 
Army hospitals in Iran during May 2007 to May 2008. All isolates were examined for antimicrobial resistance using disc 
diffusion method. 
Results: The most frequent pathogens were E. coli (32.08%) followed by K. pneumoniae (31%), P. aeruginosa (12.8%) and 
Acinetobacter spp. (9.1%). High rate of resistance to third generation cephalosporines was observed among isolates of E. 
coli and K. pneumoniae. Production of extended spectrum beta lactamases (ESBLs) was found in 46.6% of isolates of both 
organisms, but in 38% of all Gram negative bacteria. 
Conclusion:  The  prevalence  of  ESBL  producing  strains  at  three Army  Hospitals  is  considerable  (38%).  However, 
resistance to imipenem has emerged in these hospitals. Furthermore, studies are required to clarify the situation with 
multi-drug resistant organisms including the Gram positive bacteria at Army hospitals.  
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INTRODUCTION
A considerable number of critically ill patients, in 
particular  those  staying  in  ICUs,  acquire  different 
infections  following  hospitalization  (1–4).  Many 
factors  affect  the  risk  of  nosocomial  infections 
including  underlying  disease,  severity  of  illness, 
length of ICU stay, and usage of invasive devices and 
procedures. These infections have been reported to 
affect approximately 2 million hospitalized patients 
in the US annually and have imposed 57.6 billion 
dollars in expense to the US health system in 2000 
(5, 6). The beds at ICUs consisted of 5 to 10% of 
all  hospital  beds  but  they  account  for  10–25%  of 
health-care costs generated (7). The patient in the   
ICU  has  a  5-  to7-fold  higher  risk  of  nosocomial 
infection compared with the other patients. This is 
a  consequen-ce  of  impaired  defense  mechanism, 
applying invasive methods and monitoring devices, 
exposure  to  broad-spectrum  antibiotics,  and  the 
colonization  of  resistant  microorganisms.  The 
frequent use of broad-spectrum antibiotics results in 
colonization  with  resistant  Gram-negative  bacteria 
and consequently in serious infec-tions (8, 9). ICUs 
accommodate  the  most  seriously  ill  patients  in  a 
relatively confined environment. Increased duration 
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of stay, increased number of indwelling devices and 
prolonged or inappropriate use of antibiotics on the 
ICU-leading  to  selection  of  multi-resistant  ‘super-
bugs’-are all associated with significantly increased 
mortality (10-12). The highest rates of nosocomial 
infections are observed in ICUs, which are also the 
units in which the most severely ill patients are treated 
and in which the highest mortality rates are observed 
(13). The purpose of this study was to investigate 
the  antimicrobial  resistance  patterns  among  gram-
negative bacteria isolated from patients who were 
admitted to ICUs and acquired infection at 3 army 
hospitals in Tehran. 
 
MATeRIAl AND MeThODS
This is a cross-sectional study carried out in 3 Army 
hospitals (A, B, C) in Tehran, Iran, during May 2007 
to May 2008. 
patients  and  Bacterial  strains.  All  bacterial 
isolates  recovered  from  patients  of  ICUs  were 
identified based on their characteristic appearance on 
the media and the patterns of biochemical reactions 
using  conventional  bacteriological  methods  (14). 
Patients were included in the study if they showed no 
sign of infection at the time of admission and were 
not in the incubation period of any infection. They 
were diagnosed to have nosocomial infections within 
48 to 72 h following their admission as defined by 
the Centers for Disease Control (15). The specimen 
sources  included  blood,  urine,  cerebrospinal  fluid, 
respiratory tract (collected during bronchoscopy or 
endotracheal suction), tip of central venous catheters, 
bedsores, and surgical incision sites.
Susceptibility  testing.  The  susceptibility  of  the 
isolated  gram  negative  bacteria  were  tested  against 
imipenem (10 µg), nitrofurantoin (100 µg), ampicillin 
(10 µg), trimethoprim/sulfomethoxazole (1.25/1.23 µg), 
ciprofloxacin (30 µg), cefotaxim (30 µg), ceftazidime 
(30  µg),  cefepime  (30  µg),  piperacillin  (100  µg), 
amikacin  (30  µg),  ceftriaxone  (30  µg),  piperacillin-
tazobactam  (100/10  µg),  gentamicin  (30  µg)  using 
the Kirby-Bauer disc-diffusion technique as described 
by the  NCCLS (16). Quality control was assured by 
concurrent testing with the American Type Culture 
Collection (ATCC) strains including E. coli ATCC 
25921, P. aeruginosa ATCC 27852 and Staphylococ-
cus aureus ATCC25923.
The combined disks (10 μg of clavulanic acid plus 
30  μg  of  ceftazidime/cefotaxime)  in  parallel  with 
these  cephalosporines  were  used  for  detection  of 
extended spectrum beta-lactamases (ESBLs) (17). 
Statistical  analysis.  Statistical  analysis  was 
performed using SPSS version 16. All tests were two-
tailed and p < 0.05 was considered significant. 
ReSUlTS
Of 904 patients who stayed at ICUs, 187 (20.8%) 
were infected with Gram negative bacilli  during May 
2007 - May 2008 and these belonged to Hospitals: 
A (n = 70, 37.43%), B (n =  48, 25.66%) and C (n = 69, 
36.89%). Other organisms causing nosocomial infec-
tions in these hospitals were Candida spp., (n = 36) 
and gram positive bacteria (n = 50). 
Among  the  studied  patients,  56.1%  (105  cases) 
were male and 43.9% (82 cases) were female. The 
mean age of the patients was 64.46 years (range 16-
 Total   (%) Number of patients  (%) infected with nosocomial Infections
Microorganisms
Surgical site infection primary septicemia pneumonia UTI
60 (32.08) 1 (33.33%) 0 (0) 5 (6.84%) 54 (50.94%) Escherichia coli
58 (31.1) 1 (33.33%) 1 (25%) 45 (61.64%) 11 (10.37%) Klebsiella Pneumoniae
24 (12.8) 0 (0) 0 (0) 12 (16.43%) 12 (11.32%) Pseudomonas aeruginosa
17 (9.1) 0 (0) 2 (40%) 5 (6.84%) 10 (9.4%) Acinetobacter bumannii
12 (6.4) 0 (0) 2 (40%) 4 (5.47%) 6 (5.6%) Enterobacter aerogenes
8 (4.3) 1 (33.33%) 0 (0) 0 (0) 7 (6.6%) Proteus mirabilis
5 (2.7) 0 (0) 0 (0) 1 (1.36%) 4 (3.77%) Citrobacter
2  (1.1) 0 (0) 0 (0) 0 (0) 2 (1.88%) Seratia
1  (0.5) 0 (0) 0 (0) 1 (1.36%) 0 (0) Alcaligenes
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95, SD ± 19.8). The mean hospitalization for patients 
with  nosocomial  infections  was  17.27  days.  The 
primary reasons for hospitalization were malignancies, 
infections,  fracture,  operation,  kidney  dysfunction, 
poisoning, convulsions and cardiac diseases. Patients 
with heart disease were the largest group who got 
nosocomial infections in this study. The underlying 
disease such as diabetes, cardiac and renal dysfunction 
were found in 121 (64.7%) of patients. Patients who 
had undergone implant utilization made 73.8% (n = 
138) of population (with a mean of 11.36 days implant 
usage). Of 187 patients in this study, 57 (30.5%) had 
history of operation. 
Statistical analysis found correlation between usage 
of antibiotics and occurrence of nosocomial infection. 
There  was  not  significant  difference  between  the 
genders and nosocomial infection (P < 0.05). The mean 
duration of stay at ICUs was 10.34 days (SD ± 11.21). 
The mean duration for hospital stay for patients who 
got nosocomial infection was 17.27 days (17.57). 
The  most  frequent  nosocomial  infection  was 
urinary tract infection (UTI) (106 patients, 56.7%) 
followed by pneumonia (73 patients, 39%), primary 
septicemia (5 patients, 2.7%), surgical site infection 
(3 patients, 1.6%). The frequency of different gram 
negative bacteria caused UTI, pneumonia, septicemia 
and surgical site infections in this study is shown in 
Table 1.
High rate of resistance to third generation cepholos-
porins was observed among isolates of E. coli and 
K.  pneumoniae.    Production  of  ESBLs  was  found 
in 46.6% of isolates of both organisms, but in 38% 
of  Gram  negative  bacteria.  Bacteria  other  than 
E.  coli  and  Kebsiella  pneumoniae  also  showed 
resistance  to  beta  lactam  containing  antibiotics 
(Table 2). For example, all isolates of Acinetobacter 
baumannii were resistant to ampicillin, cefotaxime 
and ceftriaxone (100%). Other antibiotics including 
ciprofloxacin and aminoglyosides poorly responded 
in vitro (Table 2).  
DISCUSSION
Antimicrobial resistance is an increasingly emerging 
problem worldwide, especially in ICUs. Identifying 
the  resistance  pattern  of  microorganisms  in  every 
hospital  is  the  key  to  success  in  the  appropriate 
treatment of patients. The incidence of nosocomial 
infections with gram negative bacteria in the studied 
hospitals was 21%. 
E. coli and K. pneumoniae were the most common 
organisms  involved  in  UTI  and  respiratory  tract 
infections respectively. In our study, the most frequent 
nosocomial  infection  was  urinary  tract  infection 
(56.7%)  followed  by  pneumonia  (39%),  primary 
septicemia (2.7%), surgical site infection (1.6%). This is 
different from previous report from a teaching hospital 
in Tehran where primary septicemia (28.4) followed 
by pneumoniae (25.8%) had been found as the most 
frequent  nosocomial  infection  (18).  Pneumonia  has 




0 (0.0) 0 (0.0) 0 (0.0) 1 (12.5) 0 (0.0) 7 (41.2) 4 (16.66) 2 (3.4) 1 (1.6) Imipenem
0 (0.0) 0 (0.0) 3 (60.0) 6 (75.0) 4 (33.3) 16 (94.1) 24 (100) 33 (56.9) 10 (16.66) Nitrofurantoin 
1 (100) 2 (100) 5 (100) 8 (100) 12 (100) 17 (100) 22 (91.66) 57 (98.3) 53 (88.33) Ampicillin
1 (100) 1(50.0) 4 (80.0) 6 (75.0) 5 (41.7) 14 (82.4) 21 (87.5) 37 (63.8) 35 (58.33)
Trimethoprim/
Sulphamethoxazole
1 (100) 1 (50.0) 3 (60.0) 1 (12.5) 5 (41.7) 9 (52.9) 6 (25.0) 37 (63.8) 36 (60.0) Ciprofloxacin 
1 (100) 1 (50.0) 3 (60.0) 5 (62.5) 7 (58.3) 17 (100) 16 (66.66) 48 (82.8) 36 (60.0) Cefotaxime
1 (100) 1 (50.0) 2 (40.0) 2 (25.0) 7 (58.3) 16 (94.1) 10 (41.66) 48 (82.8) 37 (61.66) Ceftazidime 
1 (100) 1 (50.0) 2 (40.0) 5 (62.5) 7 (58.3) 16 (94.1) 14 (58.33) 49 (84.5) 41 (68.33) Cefepime 
1 (100) 1 (50.0) 5 (100) 5 (62.5) 6 (50.0) 15 (88.2) 10 (41.66) 50 (86.2) 45 (75.0) Piperacillin 
1 (100) 1 (50.0) 1 (20.0) 2 (25.0) 5 (41.7) 13 (76.5) 16 (66.66) 34 (58.6) 7 (11.66) Amikacin
1 (100) 1 (50.0) 2 (40.0) 3 (37.5) 6 (50.0) 17 (100) 14 (58.33) 45 (77.6) 36 (60.0) Ceftriaxone 
1 (50.0) 1 (50.0) 1 (20.0) 2 (25.0) 3 (25.0) 6 (35.3) 5 (20.83) 35 (60.3) 20 (33.33)
Piperacillin- 
tazobactam 
1 (100) 1 (50.0) 2 (40.0) 4 (50.0) 6 (50.0) 13 (76.5) 6 (25.0) 29 (50.0) 19 (31.66) Gentamicin 
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also been reported as the most frequent nosocomial 
infection in Turkey (938.8%), India (29.5%) and Oman 
(65%) (8, 19, 20). K. pneumoniae and E. coli were the 
most frequent agents from respiratory specimens and 
urinary tracts. E. coli has been reported as the most 
common microorganism  isolated from urinary tracts 
in Oman (19).
Beta-lactams are the most widely used antibiotics 
all over the world, and resistance to this antibiotic 
has resulted in a major clinical crisis (21). In Iran, 
cepholosporins are widely used due to their low rate 
of  side  effects.  This  might  be  associated  with  the 
increased risk of antimicrobial resistance.
The  findings  of  the  present  study  are  indicative 
of high resistance rates in most microorganisms. In 
the current study, the most frequency of resistance to 
antimicrobial agents was 50% to 100% for ceftriaxone, 
50%  to  94.1%  for  ceftazidime,  52.9%  to  63.8% 
for  ciprofloxacin,  58.3%  to  84.5%  for  cefepime, 
56.9% to 100% for nitrofurantoin, 88.33% to 100% 
for  ampicillin,  58.335  to  87.5%  for  trimethoprim/
sulphamethoxazole, 58.3% to 100% for cefotaxime, 
60%  for  piperacillin-  tazobactam  and  50%  for 
gentamicin.
The rate of resistance to ceftriaxone found in this 
study is lower than the previous report (22, 23).
The resistance frequency to imipenem was 1.6% for 
E. coli, and 3.4% for K. pnumoniae and 16.66% for 
P. aeruginosa, 41.2% for A. bumannii and 12.5% for 
P. mirabilis (Table 2). This is different from previous 
studies since isolates of Klebsiella spp. and E. coli  
had  been  fully  susceptible  to  imipenem.  (19,  24). 
Resistance to ceftazidime was 82.2% in our study that 
is higher than similar studies (25-27). 
 In this study, the frequency of resistance to at least 
3 antibiotics was 94.1% in case of A. baumannii. and 
82.8% in case of K. pneumoniae. In a study conducted 
in Turkey, multidrug resistance was reported to be 
45.4% in case of Acinetobacter spp. and 37.7 % in 
case of P. aeruginosa  (28).  
The prevalence of ESBLs  among the isolates of 
E. coli and K. pneumoniae (46.6%) in this study is 
close to the prevalence of blaCTX-M, one of the most 
frequent gene encoding ESBL, at one of the general 
hospital in Tehran (29).  Other gram negative bacteria 
also  showed  resistance  to  beta  lactam  containing 
antibiotics (Table 2). For example, all isolates of A. 
baumannii were resistant to ampicillin, cefotaxime 
and ceftriaxone (100%). Other antibiotics including 
ciprofloxacin and aminoglyosides poorly responded 
in vitro (Table 2).  
Considering the increasing antimicrobial resistance 
rate  in  hospitals,  a  committee  for  rational  drug 
administration is needed to collaborate with infection 
control committees. Most ICU-associated infections 
can  be  prevented  and  controlled  by  applying  the 
principle procedure and these include hand-washing, 
timely use and cessation of antibiotic therapy, timely 
change  or  removal  of  indwelling  ‘lines’,  early 
extubation and physiotherapy. The clinical specimens 
should be subjected to bacterial culture and antibiotic 
susceptibility  testing  prior  to  antibiotic  therapy  to 
determine the appropriate drug.  
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